(Q38156028)

29 August 2017

title

Current status of drug therapies for osteoporosis and the search for stem cells adapted for bone regenerative medicine (English)

1 reference

29 August 2017

0 references

regenerative medicine

1 reference

Yoshikazu Mikami

1

1 reference

29 August 2017

Taro Matsumoto

2

1 reference

29 August 2017

Koichiro Kano

3

1 reference

29 August 2017

Taku Toriumi

4

1 reference

29 August 2017

Masanori Somei

5

1 reference

29 August 2017

Masaki J Honda

6

1 reference

29 August 2017

Kazuo Komiyama

7

1 reference

29 August 2017

publication date

29 October 2013

1 reference

Anatomical Science International

29 August 2017

published in

1 reference

29 August 2017

volume

89

1 reference

29 August 2017

issue

1

1 reference

29 August 2017

page(s)

1-10

1 reference

https://scigraph.springernature.com/pub.10.1007/s12565-013-0208-8

29 August 2017

exact match

0 references

cites work

Oral squamous cell carcinoma overview

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

Effects of intermittent parathyroid hormone treatment on osteoprogenitor cells in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

Establishment in culture of pluripotential cells from mouse embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

The Effects of Parathyroid Hormone, Alendronate, or Both in Men with Osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

Adventage of mesenchymal stem cells (MSC) expansion directly from purified bone marrow CD105+ and CD271+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

Dedifferentiated fat cells convert to cardiomyocyte phenotype and repair infarcted cardiac tissue in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

Mature adipocyte-derived dedifferentiated fat cells can transdifferentiate into skeletal myocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

An overview of the regulation of bone remodelling at the cellular level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

Mature adipocyte-derived dedifferentiated fat cells exhibit multilineage potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

A tryptamine derivative, SST-VEDI-1, inhibits apoptosis and stimulates mineralization in osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

SSH-BM-I, a tryptamine derivative, stimulates mineralization in terminal osteoblast differentiation but inhibits osteogenesis of pre-committed progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

Inhibitory effects of a tryptamine derivative on ultraviolet radiation-induced apoptosis in MC3T3-E1 mouse osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

CD271/p75(NTR) inhibits the differentiation of mesenchymal stem cells into osteogenic, adipogenic, chondrogenic, and myogenic lineages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

SHED: stem cells from human exfoliated deciduous teeth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

Parathyroid hormone: an anabolic treatment for osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

Suppression of bone formation by osteoclastic expression of semaphorin 4D

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

Mature adipocyte-derived dedifferentiated fat cells can trans-differentiate into osteoblasts in vitro and in vivo only by all-trans retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

Adverse drug reactions to osteoporosis treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

Bisphosphonate-related osteonecrosis of the jaw: diagnosis, prevention, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

Mature, adipocyte derived, dedifferentiated fat cells can differentiate into smooth muscle-like cells and contribute to bladder tissue regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

Osteocyte signaling in bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

Embryonic stem cell trials for macular degeneration: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

Of mice and men: divergent risks of teriparatide-induced osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

Novel bromomelatonin derivatives suppress osteoclastic activity and increase osteoblastic activity: implications for the treatment of bone diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

Dental pulp cells for induced pluripotent stem cell banking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

Embryonic stem cell lines derived from human blastocysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

Induced pluripotent stem cells: a new technology to study human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

Viable offspring derived from fetal and adult mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

A novel preadipocyte cell line established from mouse adult mature adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

Induced pluripotent stem cell lines derived from human somatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

Induced pluripotent stem cell consensus genes: implication for the risk of tumorigenesis and cancers in induced pluripotent stem cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

Multilineage cells from human adipose tissue: implications for cell-based therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12565-013-0208-8

10.1007/S12565-013-0208-8

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference